Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 3;65(4):339-351.
doi: 10.1016/j.jacc.2014.10.065.

Secretoneurin is a novel prognostic cardiovascular biomarker associated with cardiomyocyte calcium handling

Anett Hellebø Ottesen  1 , William E Louch  2 , Cathrine R Carlson  2 , Ole J B Landsverk  3 , Jouni Kurola  4 , Rune Forstrøm Johansen  5 , Morten K Moe  6 , Jan Magnus Aronsen  2 , Arne Didrik Høiseth  7 , Hilde Jarstadmarken  2 , Ståle Nygård  2 , Magnar Bjørås  5 , Ivar Sjaastad  2 , Ville Pettilä  8 , Mats Stridsberg  9 , Torbjørn Omland  7 , Geir Christensen  2 , Helge Røsjø  10
Affiliations
Free article

Secretoneurin is a novel prognostic cardiovascular biomarker associated with cardiomyocyte calcium handling

Anett Hellebø Ottesen et al. J Am Coll Cardiol. .
Free article

Abstract

Background: Secretoneurin (SN) levels are increased in patients with heart failure (HF), but whether SN provides prognostic information and influences cardiomyocyte function is unknown.

Objectives: This study sought to evaluate the merit of SN as a cardiovascular biomarker and assess effects of SN on cardiomyocyte Ca(2+) handling.

Methods: We assessed the association between circulating SN levels and mortality in 2 patient cohorts and the functional properties of SN in experimental models.

Results: In 143 patients hospitalized for acute HF, SN levels were closely associated with mortality (n = 66) during follow-up (median 776 days; hazard ratio [lnSN]: 4.63; 95% confidence interval: 1.93 to 11.11; p = 0.001 in multivariate analysis). SN reclassified patients to their correct risk strata on top of other predictors of mortality. In 155 patients with ventricular arrhythmia-induced cardiac arrest, SN levels were also associated with short-term mortality (n = 51; hazard ratio [lnSN]: 3.33; 95% confidence interval: 1.83 to 6.05; p < 0.001 in multivariate analysis). Perfusing hearts with SN yielded markedly increased myocardial levels and SN internalized into cardiomyocytes by endocytosis. Intracellularly, SN reduced Ca(2+)/calmodulin (CaM)-dependent protein kinase II δ (CaMKIIδ) activity via direct SN-CaM and SN-CaMKII binding and attenuated CaMKIIδ-dependent phosphorylation of the ryanodine receptor. SN also reduced sarcoplasmic reticulum Ca(2+) leak, augmented sarcoplasmic reticulum Ca(2+) content, increased the magnitude and kinetics of cardiomyocyte Ca(2+) transients and contractions, and attenuated Ca(2+) sparks and waves in HF cardiomyocytes.

Conclusions: SN provided incremental prognostic information to established risk indices in acute HF and ventricular arrhythmia-induced cardiac arrest.

Keywords: Ca(2+)/calmodulin (CaM)-dependent protein kinase II; biomarker; calcium cycling/excitation-contraction coupling; ventricular arrhythmias.

PubMed Disclaimer

Comment in

MeSH terms